TimeScale Financial’s GSK GSK Stock Holding History

TimeScale Financial’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$3.88K	Hold	109	–	–	﹤0.01%	465
2023 Q1	$3.88K	Sell	109 -29	-21%	-$1.01K	﹤0.01%	448
2022 Q4	$4.06K	Hold	138	–	–	﹤0.01%	410
2022 Q3	$4K	Hold	138	–	–	﹤0.01%	402
2022 Q2	$8K	Sell	138 -29	-17%	-$1.6K	﹤0.01%	315
2022 Q1	$9K	Hold	167	–	–	﹤0.01%	317
2021 Q4	$9K	Buy	167 +1	+0.6%	+$52	﹤0.01%	316
2021 Q3	$8K	Sell	166 -79	-32%	-$3.97K	﹤0.01%	332
2021 Q2	$12K	Buy	245 +2	+0.8%	+$96	﹤0.01%	290
2021 Q1	$11K	Buy	243 +1	+0.4%	+$45	﹤0.01%	310
2020 Q4	$11K	Buy	242 +1	+0.4%	+$46	﹤0.01%	270
2020 Q3	$11K	Buy	241 +161	+201%	+$8.07K	﹤0.01%	275
2020 Q2	$4K	Hold	80	–	–	﹤0.01%	357
2020 Q1	$3K	Hold	80	–	–	﹤0.01%	359
2019 Q4	$4K	Hold	80	–	–	﹤0.01%	443
2019 Q3	$4K	Hold	80	–	–	﹤0.01%	413
2019 Q2	$4K	Buy	+80	New	+$4.01K	﹤0.01%	427

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TimeScale Financial's GSK Position: Q2 2023 in Review

TimeScale Financial held its GSK (GSK) position steady in Q2 2023 at 109 shares worth $3.88K. The position accounts for ﹤0.01% of the portfolio, ranked #465.

TimeScale Financial first reported a position in GSK in Q2 2019 and has held it in 17 quarters since. The position peaked at $12K in Q2 2021. 827 funds tracked by Wall St. Rank hold GSK as of Q2 2023.

TimeScale Financial held 109 shares of GSK worth $3.88K as of Q2 2023.
TimeScale Financial left its GSK share count unchanged in Q2 2023.
GSK made up ﹤0.01% of TimeScale Financial's portfolio in Q2 2023, its #465 holding.
TimeScale Financial first reported a position in GSK in Q2 2019 and has held it in 17 quarters since.
TimeScale Financial's GSK position peaked at $12K in Q2 2021.
827 funds tracked by Wall St. Rank held GSK as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.